...
首页> 外文期刊>Journal of clinical biochemistry and nutrition. >Gastric peroxisome proliferator activator receptor-γ expression and cytoprotective actions of its ligands against ischemia-reperfusion injury in rats
【24h】

Gastric peroxisome proliferator activator receptor-γ expression and cytoprotective actions of its ligands against ischemia-reperfusion injury in rats

机译:胃过氧化物酶体增殖物激活剂受体γ的表达及其配体对大鼠缺血再灌注损伤的细胞保护作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The beneficial effects by peroxisome proliferator-activated receptor-γ (PPAR-γ) on gastric injury induced by ischemia-reperfusion have been confirmed, however, the precise mechanism of its cytoprotection is not elucidated thoroughly. The aim of the present study was to determine the gastric localization of PPAR-γ expression in the rat gastric mucosa, and to clarify the mechanism of its cytoprotective properties. The gastric expression of PPAR-γ was confirmed by RT-PCR and western blot, and localized on gastric epithelial cells. The protective effect of PPAR-γ ligands, pioglitazone or 15-deoxy-Δ12,14-prostaglandin J2, on gastric ischemia-reperfusion injury was reversed by the co-administration with PPAR-γ antagonist. The gastric expression of tumor necrosis factor-α and cytokine-induced neutrophil chemoattractant-1 increased significantly in rats treated ischemia-reperfusion, and these increases were significantly inhibited by treatment with pioglitazone. Among the 1,032 probes, 18 probes were up-regulated at least 1.5-fold, 17 were down-regulated at least 1.5-fold by pioglitazone. The network including calnexin, endoplasmic reticulum stress protein, heat shock proteins, and proteasome genes was induced by pioglitazone treatment. In conclusion, activation of gastric epithelial PPAR-γ receptor by its ligands may represent a novel therapeutic approach for gastric inflammation via up-regulation of heat shock proteins and endoplasmic reticulum-related proteins.
机译:过氧化物酶体增殖物激活受体-γ(PPAR-γ)对缺血-再灌注引起的胃损伤的有益作用已得到证实,但其细胞保护的确切机制尚未完全阐明。本研究的目的是确定大鼠胃黏膜中PPAR-γ表达的胃定位,并阐明其细胞保护特性的机制。通过RT-PCR和蛋白质印迹证实了PPAR-γ的胃表达,并定位在胃上皮细胞上。 PPAR-γ配体,吡格列酮或15-脱氧-Δ 12,14 -前列腺素J 2 对胃缺血-再灌注损伤的保护作用被逆转。与PPAR-γ拮抗剂合用。在缺血再灌注大鼠中,胃肿瘤坏死因子-α和细胞因子诱导的中性粒细胞趋化因子-1的胃表达显着增加,而吡格列酮治疗显着抑制了这些增加。在1,032个探针中,吡格列酮将18个探针上调至少1.5倍,将17个探针下调至少1.5倍。通过吡格列酮处理诱导了包括钙粘蛋白,内质网应激蛋白,热休克蛋白和蛋白酶体基因的网络。总之,通过其配体激活胃上皮PPAR-γ受体可能代表通过上调热休克蛋白和内质网相关蛋白来治疗胃部炎症的新方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号